A carbon monoxide releasing metal organic framework nanoplatform for synergistic treatment of triple-negative breast tumors.
J Nanobiotechnology
; 20(1): 494, 2022 Nov 24.
Article
in En
| MEDLINE
| ID: mdl-36424645
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ruthenium
/
Triple Negative Breast Neoplasms
/
Metal-Organic Frameworks
Limits:
Humans
Language:
En
Journal:
J Nanobiotechnology
Year:
2022
Document type:
Article